Chandan Kanta Das

1.2k total citations
20 papers, 816 citations indexed

About

Chandan Kanta Das is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Chandan Kanta Das has authored 20 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Chandan Kanta Das's work include Autophagy in Disease and Therapy (10 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Chandan Kanta Das is often cited by papers focused on Autophagy in Disease and Therapy (10 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). Chandan Kanta Das collaborates with scholars based in India, United States and Germany. Chandan Kanta Das's co-authors include Mahitosh Mandal, Donat Kögel, Sujit K. Bhutia, Indranil Banerjee, Ranabir Majumder, Bikash Chandra Jena, Pratap Parida, Aditya Parekh, Subhayan Das and Prajna Paramita Naik and has published in prestigious journals such as Cancer Research, Biochemical Pharmacology and Experimental Cell Research.

In The Last Decade

Chandan Kanta Das

20 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chandan Kanta Das India	13	486	253	236	157	69	20	816
Yuhe Lei China	15	795 1.6×	347 1.4×	332 1.4×	217 1.4×	45 0.7×	28	1.2k
Biaoyan Du China	17	506 1.0×	121 0.5×	138 0.6×	118 0.8×	54 0.8×	34	793
Maria Rita Emma Italy	18	456 0.9×	123 0.5×	152 0.6×	116 0.7×	33 0.5×	25	846
Soumya Ranjan Mishra India	16	718 1.5×	383 1.5×	190 0.8×	92 0.6×	41 0.6×	30	1.1k
Alena Hyršlová Vaculová Czechia	21	784 1.6×	121 0.5×	313 1.3×	224 1.4×	75 1.1×	43	1.2k
Mohamed Elgendy Italy	13	766 1.6×	413 1.6×	209 0.9×	199 1.3×	37 0.5×	21	1.2k
Kewal Kumar Mahapatra India	17	781 1.6×	490 1.9×	237 1.0×	111 0.7×	51 0.7×	30	1.2k
Huijie Guo China	17	456 0.9×	130 0.5×	223 0.9×	181 1.2×	24 0.3×	38	872
Keli Tian China	16	594 1.2×	98 0.4×	197 0.8×	122 0.8×	30 0.4×	30	964

Countries citing papers authored by Chandan Kanta Das

Since Specialization

Citations

This map shows the geographic impact of Chandan Kanta Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandan Kanta Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandan Kanta Das more than expected).

Fields of papers citing papers by Chandan Kanta Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandan Kanta Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandan Kanta Das. The network helps show where Chandan Kanta Das may publish in the future.

Co-authorship network of co-authors of Chandan Kanta Das

This figure shows the co-authorship network connecting the top 25 collaborators of Chandan Kanta Das. A scholar is included among the top collaborators of Chandan Kanta Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandan Kanta Das. Chandan Kanta Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roy, Pritam, Chandan Kanta Das, Abhijit Das, et al.. (2025). PSMC2 promotes resistance against temozolomide in glioblastoma via suppressing JNK-mediated autophagic cell death. Biochemical Pharmacology. 233. 116755–116755. 3 indexed citations

Roy, Pritam, et al.. (2025). PSMC2 upregulation enhances epithelial-to-mesenchymal transition in glioblastoma via activating AKT/GSK3β/β-catenin axis. Cellular Signalling. 132. 111809–111809. 2 indexed citations

Roy, Pritam, et al.. (2024). Mitophagy at the crossroads of cancer development: Exploring the role of mitophagy in tumor progression and therapy resistance. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(6). 119752–119752. 15 indexed citations

Kundu, Moumita, Subhayan Das, Chandan Kanta Das, et al.. (2023). Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K/AKT/mTOR signaling. Experimental Cell Research. 424(1). 113488–113488. 11 indexed citations

Deng, Qu, Ramakrishnan Natesan, Florencia Cidre‐Aranaz, et al.. (2022). Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1. Cell Reports. 39(11). 110971–110971. 8 indexed citations

Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2022). TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation. Experimental Cell Research. 417(1). 113195–113195. 36 indexed citations

Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2022). TGF-β1 Induced Autophagy in Cancer Associated Fibroblasts During Hypoxia Contributes EMT and Glycolysis Via MCT4 Upregulation. SSRN Electronic Journal. 1 indexed citations

Jena, Bikash Chandra, Chandan Kanta Das, Indranil Banerjee, et al.. (2021). Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway. Biochemical Pharmacology. 186. 114474–114474. 41 indexed citations

Majumder, Ranabir, Chandan Kanta Das, Indranil Banerjee, et al.. (2021). Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA. Computers in Biology and Medicine. 141. 105052–105052. 19 indexed citations

10.

Jena, Bikash Chandra, et al.. (2020). Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(2). 188416–188416. 58 indexed citations

11.

Das, Chandan Kanta, Aditya Parekh, Pratap Parida, Sujit K. Bhutia, & Mahitosh Mandal. (2019). Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(6). 1004–1018. 105 indexed citations

12.

Banerjee, Indranil, Subhayan Das, Chandan Kanta Das, et al.. (2019). Abstract 3638: Combination of metformin and metronomic liposomal doxorubicin exerts a robust anticancer effect in triple negative breast cancer by inhibiting breast cancer stem cells & the Wnt/beta-catenin pathway. Cancer Research. 79(13_Supplement). 3638–3638. 1 indexed citations

13.

Das, Chandan Kanta, Indranil Banerjee, & Mahitosh Mandal. (2019). Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer. Seminars in Cancer Biology. 66. 59–74. 45 indexed citations

14.

Majumder, Ranabir, Chandan Kanta Das, & Mahitosh Mandal. (2019). Lead bioactive compounds of Aloe vera as potential anticancer agent. Pharmacological Research. 148. 104416–104416. 67 indexed citations

15.

Das, Chandan Kanta, Benedikt Linder, Florian Bonn, et al.. (2018). BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells. Neoplasia. 20(3). 263–279. 74 indexed citations

16.

Das, Chandan Kanta, Mahitosh Mandal, & Donat Kögel. (2018). Pro-survival autophagy and cancer cell resistance to therapy. Cancer and Metastasis Reviews. 37(4). 749–766. 138 indexed citations

17.

Das, Chandan Kanta, Bikash Chandra Jena, Subhayan Das, et al.. (2018). Abstract 1348: Parkin-mediated mitophagy regulates 5-fluorouracil-induced chemoresistance in breast cancer. Cancer Research. 78(13_Supplement). 1348–1348. 1 indexed citations

18.

Naik, Prajna Paramita, Subhadip Mukhopadhyay, Prashanta Kumar Panda, et al.. (2017). Autophagy regulates cisplatin‐induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma. Cell Proliferation. 51(1). 99 indexed citations

19.

Bharti, Rashmi, Goutam Dey, Indranil Banerjee, et al.. (2016). Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Cancer Letters. 388. 292–302. 66 indexed citations

20.

Dey, Goutam, Rashmi Bharti, Indranil Banerjee, et al.. (2016). Pre-clinical risk assessment and therapeutic potential of antitumor lipopeptide ‘Iturin A’ in an in vivo and in vitro model. RSC Advances. 6(75). 71612–71623. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact